Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for JNJ
Company Monitoring Page for JNJ
latest headlines for company on cafepharma
J&J bites back against dengue, linking antiviral to protection from infection in challenge trial
Fierce Biotech
Fri, 10/20/23 - 10:15 am
Tags:
JNJ
,
dengue
,
JNJ-1802
,
antiviral
Lung Cancer Takes Center Stage at ESMO Congress 2023 With New Drugs, More Options
OBR Oncology
Fri, 10/20/23 - 10:05 am
Tags:
ESMO
,
non-small cell lung cancer
,
Roche
,
Alecensa
,
AstraZeneca
,
Tagrisso
,
JNJ
,
Rybrevant
Could J&J’s Rybrevant-based combo disrupt AstraZeneca’s Tagrisso in lung cancer faceoff?
Medical Marketing and Media
Thu, 10/19/23 - 11:29 am
Tags:
JNJ
,
Rybrevant
,
AstraZeneca
,
Tagrisso
,
EGFR-mutated NSCLC
After launch limitations, Johnson & Johnson exec touts manufacturing progress on CAR-T drug Carvykti
Fierce Pharma
Wed, 10/18/23 - 07:44 pm
Tags:
JNJ
,
Legend Biotech
,
Multiple Myeloma
,
CAR-T
,
Carvykti
,
cell therapy
Why Johnson & Johnson Stock Flopped Today
Motley Fool
Wed, 10/18/23 - 07:39 pm
Tags:
JNJ
,
earnings
,
analysts
J&J Signals Exit from Less Profitable Orthopedic Markets
Medical Devices and Diagnostics Industry
Wed, 10/18/23 - 10:14 am
Tags:
JNJ
,
Medtech
,
Orthopedics
J&J Sees Nearly 7% Growth in Q3, Increases Full-Year Guidance
BioSpace
Tue, 10/17/23 - 09:39 pm
Tags:
JNJ
,
earnings
Janssen’s Tremfya maintains three years of remission in Phase II Crohn’s disease trial
Clinical Trials Arena
Tue, 10/17/23 - 11:45 am
Tags:
JNJ
,
Janssen
,
clinical trials
,
Crohn's Disease
,
Tremfya
FDA Warning Letter to J&J's Abiomed Has Broad Implications for Medtech
Medical Devices and Diagnostics Industry
Tue, 10/17/23 - 10:20 am
Tags:
Medtech
,
JNJ
,
FDA
,
warning letters
AbbVie trumpets Skyrizi's resounding win against J&J's Stelara in Crohn's disease
Fierce Pharma
Mon, 10/16/23 - 11:50 am
Tags:
AbbVie
,
Akyrizi
,
JNJ
,
Stelara
,
Crohn's Disease
FDA Rejects Alvotech’s Stelara Biosimilar as Manufacturing Problems Continue
BioSpace
Thu, 10/12/23 - 10:22 am
Tags:
Alvotech
,
AVT04
,
JNJ
,
Stelara
,
biosimilars
,
FDA
J&J could reach market-leading medtech growth after consumer spinoff: analysts
Medtech Dive
Tue, 10/10/23 - 10:20 am
Tags:
JNJ
,
Medtech
,
spinoffs
,
Kenvue
J&J’s Spravato Bests Quetiapine in Phase III Head-to-Head Depression Study
BioSpace
Thu, 10/5/23 - 10:14 am
Tags:
JNJ
,
clinical trials
,
Spravato
,
treatment-resistant depression
,
depression
,
Quetiapine
Johnson & Johnson gets a talc win as New Jersey court erases $223M jury award
Fierce Pharma
Wed, 10/4/23 - 11:06 am
Tags:
JNJ
,
legal
Sanofi pays J&J $175M for late-phase E. coli shot, pushing deeper into vaccines as partner retreats
Fierce Biotech
Tue, 10/3/23 - 10:15 am
Tags:
Sanofi
,
JNJ
,
vaccines
,
E. coli
Johnson & Johnson says it won't enforce secondary patents on tuberculosis med Sirturo
Fierce Pharma
Mon, 10/2/23 - 06:37 pm
Tags:
JNJ
,
Sirturo
,
tuberculosis
,
patents
Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?
Motley Fool
Sun, 10/1/23 - 01:07 pm
Tags:
JNJ
,
Kenvue
,
consumer health
,
spinoffs
,
dividends
J&J's lung cancer therapy succeeds in head-to-head study with AstraZeneca's drug
Reuters
Thu, 09/28/23 - 12:08 pm
Tags:
JNJ
,
non-small cell lung cancer
,
AstraZeneca
,
Rybrevant
,
lazertinib
,
Tagrisso
Janssen and Atropos partner to expedite clinical development
Clinical Trials Arena
Thu, 09/28/23 - 10:10 am
Tags:
JNJ
,
Janssen
,
Atropos Health
,
real world data
J&J inks 'first of its kind' pact with Singapore government to boost regional life sciences innovation
Fierce Biotech
Wed, 09/27/23 - 11:47 am
Tags:
JNJ
,
Singapore
,
life sciences
,
JLabs
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.